Kornberg A - Search Results

1

Sustained renal response to mycophenolate mofetil and CNI taper promotes survival in liver transplant patients with CNI-related renal dysfunction.

Kornberg A, Küpper B, Thrum K, Krause B, Büchler P, Kornberg J, Sappler A, Altendorf-Hofmann A, Wilberg J, Friess H. Kornberg A, et al. Among authors: kornberg j. Dig Dis Sci. 2011 Jan;56(1):244-51. doi: 10.1007/s10620-010-1386-z. Epub 2010 Sep 8. Dig Dis Sci. 2011. PMID: 20824504

2

Cerebral toxoplasmosis after combined liver-pancreas-kidney and liver-pancreas transplantation.

Hommann M, Schotte U, Voigt R, Glutig H, Grube T, Küpper B, Kornberg A, Richter K, Scheele J. Hommann M, et al. Among authors: kornberg a. Transplant Proc. 2002 Sep;34(6):2294-5. doi: 10.1016/s0041-1345(02)03241-4. Transplant Proc. 2002. PMID: 12270404 No abstract available.

3

Impact of selective prostaglandin E1 treatment on graft perfusion and function after liver transplantation.

Kornberg A, Schotte U, Kupper B, Hommann M, Scheele J. Kornberg A, et al. Hepatogastroenterology. 2004 Mar-Apr;51(56):526-31. Hepatogastroenterology. 2004. PMID: 15086195

4

Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation.

Kornberg A, Küpper B, Tannapfel A, Hommann M, Scheele J. Kornberg A, et al. Int Immunopharmacol. 2005 Jan;5(1):107-15. doi: 10.1016/j.intimp.2004.09.010. Int Immunopharmacol. 2005. PMID: 15589468 Clinical Trial.

5

Introduction of MMF in conjunction with stepwise reduction of calcineurin inhibitor in stable liver transplant patients with renal dysfunction.

Kornberg A, Küpper B, Hommann M, Scheele J. Kornberg A, et al. Int Immunopharmacol. 2005 Jan;5(1):141-6. doi: 10.1016/j.intimp.2004.09.018. Int Immunopharmacol. 2005. PMID: 15589474 Clinical Trial.

6

Antiviral treatment withdrawal in viremic HCV-positive liver transplant patients: impact on viral loads, allograft function and morphology.

Kornberg A, Küpper B, Tannapfel A, Thrum K, Bärthel E, Settmacher U. Kornberg A, et al. Liver Int. 2006 Sep;26(7):811-6. doi: 10.1111/j.1478-3231.2006.01301.x. Liver Int. 2006. PMID: 16911463

7

Prevention of early loss of bone mineral density after liver transplantation by prostaglandin E1.

Hommann M, Kämmerer D, Lehmann G, Kornberg A, Küpper B, Daffner W, Wolf G, Settmacher U. Hommann M, et al. Among authors: kornberg a. Transplant Proc. 2007 Mar;39(2):540-3. doi: 10.1016/j.transproceed.2006.12.016. Transplant Proc. 2007. PMID: 17362777

8

Conversion to mycophenolate mofetil for modulating recurrent hepatitis C in liver transplant recipients.

Kornberg A, Küpper B, Wilberg J, Tannapfel A, Thrum K, Bärthel E, Hommann M, Settmacher U. Kornberg A, et al. Transpl Infect Dis. 2007 Dec;9(4):295-301. doi: 10.1111/j.1399-3062.2007.00228.x. Epub 2007 May 19. Transpl Infect Dis. 2007. PMID: 17511824 Clinical Trial.

9

Adjuvant conversion to sirolimus in liver transplant patients with recurrent hepatocellular carcinoma - preliminary results.

Kornberg A, Küpper B, Tannapfel A, Thrum K, Wilberg J, Bärthel E, Settmacher U. Kornberg A, et al. Transpl Int. 2008 Jan;21(1):96-9. doi: 10.1111/j.1432-2277.2007.00567.x. Epub 2007 Sep 28. Transpl Int. 2008. PMID: 17903182 Free article. No abstract available.

10

Antiviral maintenance treatment with interferon and ribavirin for recurrent hepatitis C after liver transplantation: pilot study.

Kornberg A, Küpper B, Tannapfel A, Bärthel E, Thrum K, Settmacher U. Kornberg A, et al. J Gastroenterol Hepatol. 2007 Dec;22(12):2135-42. doi: 10.1111/j.1440-1746.2006.04516.x. J Gastroenterol Hepatol. 2007. PMID: 18031371 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

679 results

Search Page

Filters